Quick Answer
Caribou Biosciences, Inc. reported Stockholders Equity of $122.17 million for fiscal year 2025.
Caribou Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $122.17M | -51.7% |
| 2024 | $252.95M | -31.3% |
| 2023 | $368.40M | +22.4% |
| 2022 | $300.87M | -22.4% |
| 2021 | $387.82M | +1754.8% |
| 2020 | -$23.44M | -414.0% |
| 2019 | $7.46M | -75.1% |
| 2018 | $29.95M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $141.84M | -49.6% | -14.6% |
| June 30, 2025 | $166.13M | -46.5% | -23.5% |
| March 31, 2025 | $217.22M | -36.7% | -14.1% |
| December 31, 2024 | $252.95M | -31.3% | -10.0% |
| September 30, 2024 | $281.20M | -29.4% | -9.4% |
| June 30, 2024 | $310.46M | +15.2% | -9.6% |
| March 31, 2024 | $343.29M | +23.4% | -6.8% |
| December 31, 2023 | $368.40M | +22.4% | -7.5% |
- Caribou Biosciences, Inc. showed a decrease of -51.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Caribou Biosciences, Inc.’s stockholders equity has grown by 308.0% (from $29.95 million to $122.17 million).
- The most recent figure is from Caribou Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: